Compare NEUP & PMEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | NEUP | PMEC |
|---|---|---|
| Founded | 1996 | 1984 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.5M | 20.7M |
| IPO Year | 2002 | 2021 |
| Metric | NEUP | PMEC |
|---|---|---|
| Price | $3.38 | $0.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 16.3K | ★ 29.1K |
| Earning Date | 11-13-2026 | 07-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,174,165.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.19 | $0.31 |
| 52 Week High | $6.00 | $1.91 |
| Indicator | NEUP | PMEC |
|---|---|---|
| Relative Strength Index (RSI) | 41.87 | 32.92 |
| Support Level | $3.24 | $0.31 |
| Resistance Level | $4.15 | $0.79 |
| Average True Range (ATR) | 0.11 | 0.05 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 43.76 | 11.73 |
Neuphoria Therapeutics Inc is a clinical-stage biotechnology company focused on therapies for serious central nervous system disorders. Its lead product candidate, BNC210, is an oral, proprietary, selective negative allosteric modulator of the alpha7 nicotinic acetylcholine receptor. The company has discontinued development of BNC210 for social anxiety disorder, while its BNC210 program for post-traumatic stress disorder is currently paused and no active clinical trial is underway. The company operates through a single operating and reporting segment focused on the discovery and development of allosteric ion-channel modulators for serious CNS disorders with high unmet medical need.
Primech Holdings Ltd is a Singapore-based facilities services and AI robotics group with operations in Singapore and Hong Kong. Through its subsidiaries, the company provides integrated facilities management, cleaning and stewarding services to the public and private sectors, serving airports, educational institutions, healthcare facilities, commercial buildings and hospitality venues. It also develops HYTRON, an autonomous restroom-cleaning robot that uses AI perception and robotic manipulation. In addition, the company operates HomeHelpy, a digital platform for booking home services for consumers.